Human immune response to Vibrio cholerae O1 whole cells and isolated outer membrane antigens

The serum immunoglobulin G (IgG) and mucosal secretory IgA (SIgA) response of human volunteers challenged with Vibrio cholerae O1 was analyzed for reactivity to V. cholerae O1 antigens by the immunoblot technique. Components of both in vitro- and in vivo (rabbit ligated ileal loop)-grown V. cholerae O1 were separated by sodium dodecyl sulfate-urea-polyacrylamide gel electrophoresis. Postchallenge serum IgG reacted uniquely with 15 antigens and with greater intensity than did prechallenge serum with at least 16 antigens. Serum IgG and SIgA reacted with antigens present in preparations from the homologous challenge strain of V. cholerae as well as antigens from strains of heterologous biotype or serotype. These heterologous antigens may represent antigens responsible for protection to rechallenge with a heterologous strain of V. cholerae. All the antigens detected by postchallenge jejunal fluid SIgA had an apparent molecular size of less than 25 kilodaltons. Serum IgG and jejunal fluid SIgA also reacted with antigens unique to in vivo-grown cells and several antigens in outer membrane preparations, suggesting that studies of protective immunity and V. cholerae O1 pathogenesis should include examination of both in vitro- and in vivo-grown V. cholerae O1 cellular antigens.

[1]  M. Levine,et al.  Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin , 1987, Infection and immunity.

[2]  K. Aziz,et al.  The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests. , 1970, The Journal of infectious diseases.

[3]  C. Sciortino,et al.  Vibrio cholerae expresses iron-regulated outer membrane proteins in vivo , 1983, Infection and immunity.

[4]  L. Thomashow,et al.  Isolation and composition of sheathed flagella from Bdellovibrio bacteriovorus 109J , 1985, Journal of bacteriology.

[5]  M. Levine,et al.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. , 1983, Microbiological reviews.

[6]  L. Cisneros,et al.  Duration of infection-derived immunity to cholera. , 1981, The Journal of infectious diseases.

[7]  V. L. Miller,et al.  Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Levine Immunity to Cholera as Evaluated in Volunteers , 1980 .

[9]  S. Attridge,et al.  Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae. , 1983, The Journal of infectious diseases.

[10]  S. Payne,et al.  Effect of iron limitation on growth, siderophore production, and expression of outer membrane proteins of Vibrio cholerae , 1982, Journal of bacteriology.

[11]  N. Pierce,et al.  Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine. , 1974, The Journal of infectious diseases.

[12]  M. Levine,et al.  Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques , 1988, Infection and immunity.

[13]  W. Cray,et al.  M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration. , 1986, The Journal of infectious diseases.

[14]  K. Richardson,et al.  Identification and occurrence of Vibrio cholerae flagellar core proteins in isolated outer membrane , 1985, Infection and immunity.

[15]  M. Levine,et al.  A Recombinant Live Oral Cholera Vaccine , 1984, Bio/Technology.

[16]  J. Kaur,et al.  Immunity to Cholera: Relation of Fraction II of Type 2 Cholera Toxin to Vibriocidal Antibody , 1969, Journal of bacteriology.

[17]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[18]  M. Levine,et al.  Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine , 1984, Infection and immunity.

[19]  M. Levine,et al.  Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates , 1984, Nature.

[20]  M. Levine,et al.  Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. , 1982, The Journal of infectious diseases.

[21]  M. Levine,et al.  Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae , 1984, Infection and immunity.

[22]  K. Richardson,et al.  Identification and characterization of Vibrio cholerae surface proteins by radioiodination , 1985, Infection and immunity.

[23]  D. Sack,et al.  FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH , 1986, The Lancet.

[24]  S. Neoh,et al.  The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement. , 1970, The Journal of infectious diseases.

[25]  E. Gangarosa,et al.  Field Trials of Cholera Vaccine , 1980 .

[26]  R. Hawkes,et al.  A dot-immunobinding assay for monoclonal and other antibodies. , 1982, Analytical biochemistry.

[27]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Morrissey,et al.  Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. , 1981, Analytical biochemistry.

[29]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[30]  M U Khan,et al.  Endemic cholera in rural Bangladesh, 1966-1980. , 1982, American journal of epidemiology.

[31]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[32]  D. Nalin,et al.  Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity. , 1979, Transactions of the Royal Society of Tropical Medicine and Hygiene.